APLS logo

Apellis Pharmaceuticals (APLS) Interest Expense

Annual Interest Expense

$29.58 M
-$3.04 M-9.33%

31 December 2023

APLS Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Interest Expense

$12.53 M
+$3.17 M+33.90%

30 September 2024

APLS Quarterly Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Interest Expense

$36.26 M
+$5.22 M+16.82%

30 September 2024

APLS TTM Interest Expense Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

APLS Interest Expense Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-9.3%+71.4%+21.2%
3 y3 years-1.2%+449.2%+82.8%
5 y5 years+1077.1%+1981.7%+1296.6%

APLS Interest Expense High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-9.3%+123.4%at high+449.2%at high+173.8%
5 y5 years-9.3%+1077.1%at high+1981.7%at high+1296.6%
alltimeall time-9.3%at high+7781.8%at high+5335.5%

Apellis Pharmaceuticals Interest Expense History

DateAnnualQuarterlyTTM
Sept 2024
-
$12.53 M(+33.9%)
$36.26 M(+16.8%)
June 2024
-
$9.36 M(+34.3%)
$31.04 M(+7.0%)
Mar 2024
-
$6.97 M(-5.9%)
$29.02 M(-1.9%)
Dec 2023
$29.58 M(-9.3%)
$7.40 M(+1.3%)
$29.58 M(-1.1%)
Sept 2023
-
$7.31 M(-0.4%)
$29.92 M(-1.9%)
June 2023
-
$7.34 M(-2.5%)
$30.51 M(-3.5%)
Mar 2023
-
$7.53 M(-2.7%)
$31.62 M(-3.1%)
Dec 2022
$32.63 M(+146.4%)
$7.74 M(-2.1%)
$32.63 M(+16.9%)
Sept 2022
-
$7.90 M(-6.5%)
$27.91 M(+25.2%)
June 2022
-
$8.45 M(-1.1%)
$22.29 M(+26.6%)
Mar 2022
-
$8.54 M(+182.9%)
$17.61 M(+32.9%)
Dec 2021
$13.24 M
$3.02 M(+32.3%)
$13.24 M(-33.2%)
Sept 2021
-
$2.28 M(-39.4%)
$19.83 M(-26.7%)
June 2021
-
$3.77 M(-9.8%)
$27.05 M(-10.4%)
DateAnnualQuarterlyTTM
Mar 2021
-
$4.17 M(-56.6%)
$30.19 M(+0.9%)
Dec 2020
$29.94 M(+466.5%)
$9.61 M(+1.2%)
$29.94 M(+23.4%)
Sept 2020
-
$9.50 M(+37.5%)
$24.26 M(+57.9%)
June 2020
-
$6.91 M(+76.3%)
$15.36 M(+78.4%)
Mar 2020
-
$3.92 M(-0.3%)
$8.61 M(+62.9%)
Dec 2019
$5.29 M(+110.3%)
$3.93 M(+553.0%)
$5.29 M(+103.6%)
Sept 2019
-
$602.00 K(+278.6%)
$2.60 M(+1.0%)
June 2019
-
$159.00 K(-73.2%)
$2.57 M(-14.7%)
Mar 2019
-
$593.00 K(-52.3%)
$3.02 M(-2.4%)
Dec 2018
$2.51 M(+570.7%)
$1.24 M(+115.1%)
$3.09 M(+67.2%)
Sept 2018
-
$577.50 K(-4.3%)
$1.85 M(+45.4%)
June 2018
-
$603.70 K(-9.5%)
$1.27 M(+90.5%)
Mar 2018
-
$667.10 K
$667.10 K
Dec 2017
$374.70 K(>+9900.0%)
-
-
Dec 2016
$0.00
-
-

FAQ

  • What is Apellis Pharmaceuticals annual interest expense?
  • What is the all time high annual interest expense for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals annual interest expense year-on-year change?
  • What is Apellis Pharmaceuticals quarterly interest expense?
  • What is the all time high quarterly interest expense for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals quarterly interest expense year-on-year change?
  • What is Apellis Pharmaceuticals TTM interest expense?
  • What is the all time high TTM interest expense for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals TTM interest expense year-on-year change?

What is Apellis Pharmaceuticals annual interest expense?

The current annual interest expense of APLS is $29.58 M

What is the all time high annual interest expense for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high annual interest expense is $32.63 M

What is Apellis Pharmaceuticals annual interest expense year-on-year change?

Over the past year, APLS annual interest expense has changed by -$3.04 M (-9.33%)

What is Apellis Pharmaceuticals quarterly interest expense?

The current quarterly interest expense of APLS is $12.53 M

What is the all time high quarterly interest expense for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high quarterly interest expense is $12.53 M

What is Apellis Pharmaceuticals quarterly interest expense year-on-year change?

Over the past year, APLS quarterly interest expense has changed by +$5.22 M (+71.44%)

What is Apellis Pharmaceuticals TTM interest expense?

The current TTM interest expense of APLS is $36.26 M

What is the all time high TTM interest expense for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high TTM interest expense is $36.26 M

What is Apellis Pharmaceuticals TTM interest expense year-on-year change?

Over the past year, APLS TTM interest expense has changed by +$6.34 M (+21.20%)